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In this issue of Annals of Surgical Oncology, D’Angelica
and colleagues from the Memorial Sloan–Kettering Cancer
Center report data on the importance of extent of resection
for gallbladder adenocarcinoma. The analyses reveal that
extensive resections for gallbladder cancer are associated
with increased morbidity, but not survival. These findings
have important implications as some investigators have in
the past advocated extended operations that combine major
hepatic resection and routine common bile duct resection
with reconstructive hepaticojejunostomy to improve long-
term survival.1,2 Prognosis following surgery for gallblad-
der adenocarcinoma can vary dramatically, with 5-year
survival rates ranging from 10% to 90%. As noted by the
authors in their current report, outcome following surgery
depends not only on the extent of the curative resection, but
more importantly, on the stage of disease.3 D’Angelica and
colleagues reaffirm the basic oncologic tenet that tumor
biology—not extent of resection—is the dominate factor
that dictates survival.
Whether to perform empirically a nonanatomical
resection or an anatomical resection for hepatobiliary
malignancies of the liver has been controversial.4,5
Although some studies have reported that the performance
of an anatomical resection improves tumor clearance and
outcome, other reports have not demonstrated a benefit for
anatomic or ‘‘extended’’ resections.4,6 In general, most
surgeons have begun to advocate a more parenchymal-
sparing approach to resection of hepatobiliary tumors that
still maintains a negative margin. In support of this, our
group previously reported that the extent of hepatectomy
for gallbladder carcinoma was not associated with prog-
nosis.6 D’Angelica similarly noted that patients who
underwent a major hepatectomy had a 5-year actuarial
survival comparable to those patients who did not undergo
major hepatic resection. However, unlike D’Angelica et al.,
we previously reported that, rather than extent of hepatic
resection, surgical margin status was a key determinant of
outcome. Specifically, R1/R2 margin status was associated
with significantly worse long-term outcome.6 The failure of
the current authors to find margin status to be a significant
prognostic factor may be due to the laudatory fact that only
nine patients in the series had a positive resection margin.
As such, analyses involving margin status may have been
underpowered. Regardless, we agree whole-heartedly with
our colleagues that rather than dogmatically adhering to an
extended versus nonextended surgical resection approach,
the surgeon’s goal should be to resect all disease with
negative histologic margins.
Similar to the extent of hepatic resection, the wholesale
adoption of a more extensive approach to the common bile
duct may also be unwarranted. While some surgeons have
advocated routine resection of the common bile duct at the
time of curative resection and portal lymphadenectomy,
other investigators have questioned this approach.1,6,7 The
study by D’Angelica et al., as well as others, now provide
data to show that routine bile duct excision is not neces-
sarily associated with improved overall survival.6,8 The
notion that resection of the common bile duct may facili-
tate a more thorough lymphadenectomy also has been
questioned. As noted in the D’Angelica report, lymph node
counts were similar regardless of whether a common bile
duct resection had been performed. It is important to note
that, while routine common bile duct resection was not
associated with survival or lymph node yield, it was
associated with increased morbidity. In fact, D’Angelica
et al. noted a 33% incidence of grade 3/4 morbidity in the
group of patients who underwent bile duct excision and
reconstruction. Citing similar data showing no improve-
ment in long-term survival, as well as the increased risk of
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complications following a bilioenteric anastomosis, the
Makuuchi group has similarly recommended preservation
of the extrahepatic bile duct when possible.8,9 Rather than
adopting a universal approach to management of the
common bile duct, a more selective approach may be
warranted. Noting that a positive cystic duct margin—
based either on the initial cholecystectomy specimen or
intraoperative biopsy of the cystic duct stump—is strongly
associated with residual disease in the common bile duct,
our group has advocated selective common bile duct
resection in conjunction with lymphadenectomy in this
subset of patients in order to obtain an R0 resection.6
Similar to previous studies, D’Angelica et al. identified a
number of prognostic factors that stratified patients with
regard to prognosis following resection for gallbladder
carcinoma.10,11 Specifically, factors associated with poor
prognosis included advanced T- and American Joint
Committee on Cancer (AJCC) stage, as well as metastatic
nodal disease. Some surgeons have suggested that lymph
node metastasis should be a relative contraindication to
resection because poor survival is the rule.12 It should be
noted, however, that in the current study the overall 5-year
survival for patients with lymph node metastasis was about
20%. As such, resection of patients with lymph node
metastasis should still be considered. These data do,
however, serve to emphasize the importance of tumor
biology in ultimately dictating prognosis. Much more than
operative technique, tumor biology is the ultimate adjudi-
cator in determining patient long-term survival.
In summary, the authors are to be congratulated for an
insightful analysis of such a large single-institution series
of patients with gallbladder adenocarcinoma. Data from the
current study emphasized that extent of hepatic resection
does not appear to affect outcome. It is critical, however, to
perform the appropriate operation necessary to achieve
negative surgical margins. Sadly, gallbladder adenocarci-
noma frequently manifests with aggressive tumor biology.
It is unlikely that clinically significant improvements in
survival will therefore result from more extensive resection
of non-tumor-bearing hepatic parenchyma. In fact, such
resections appear to be associated with increased morbid-
ity. In light of these data from D’Angelica et al., for the
surgical patient with gallbladder cancer sometimes less
truly is more. Specifically, rather than a routine extended
resection, a more rational approach to the patient with
gallbladder cancer is to consider the extent and location of
the tumor and to plan the extent of surgery based on what is
necessary to achieve microscopically negative margins.
Given the importance of tumor biology, future resources
for investigation of gallbladder adenocarcinoma should be
directed toward the study of emerging techniques for early
diagnosis, as well as the development of novel, more
efficacious systemic treatment strategies.
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